The Food and Drug Administration issued a Complete Response Letter to Portola Pharmaceuticals Inc. (Nasdaq: PTLA) for AndexXa. The stock price plunged $3.57 to close at $20.12.
Portola Pharmaceuticals receives CRL
August 18, 2016 at 17:13 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.